Company intelligence / Profile preview

Cytogen, Inc.

Songpa-gu, Seoul, South Koreamarketscreener.com ↗

Ownership: Private
Development stage: Commercial

Overview

Cytogen has developed a proprietary platform for isolating and analyzing live circulating tumor cells from blood samples. This enables non-invasive cancer diagnostics, companion diagnostics development, drug response monitoring, biomarker discovery/validation, and recurrence prediction. The company collaborates with major hospitals and pharmaceutical companies globally.

Therapeutic areas: Oncology
Modalities: Liquid biopsy technology based on Circulating Tumor Cells (CTCs)
Industry: Molecular Diagnostics

Drug pipeline

5 assets

samarium Sm-153 lexidronam

Commercial

Indications: Bone metastases pain

4 more assets in the full pipeline.

Request access →

Partnerships

Thermo Fisher Scientific (antibody development project)Daiichi Sankyo (multiple contracts)Samsung Seoul Hospital [multiple contracts/platform supply contract], Yonsei Severance Hospital, Seoul St. Mary’s Hospital [clinical collaborations], National Cancer Center Korea [biomarker discovery], ABL Bio [biomarker collaboration], CMIC Japan [marketing partnership].

Beyond the preview

Go deeper on Cytogen, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytogen, Inc..

Explore the full profile